Exercise as medicine: new study tests if workouts can heal arteries

NCT ID NCT06579807

First seen Apr 03, 2026

Summary

This study is testing whether a 12-week supervised exercise program can improve artery health and reduce inflammation in people with coronary artery disease. Fifty participants aged 40-70 will do aerobic, resistance, and flexibility exercises three times a week. Researchers will measure artery thickness, blood vessel function, and levels of inflammation-related substances before and after the program.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Rio de Janeiro State University

    RECRUITING

    Rio de Janeiro, Rio de Janeiro, 20550-900, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

supervised exercise training (aerobic, resistance, and flexibility exercises)

What this could lead to

If it works, this could show that a structured exercise program helps slow or reverse artery damage and lower inflammation in people with heart disease.

What could go wrong

This is a small, early study with only 50 participants and no control group for the intervention, so results may not apply to everyone. Exercise is generally safe but carries a small risk of injury or cardiac events.

Conditions

The condition(s) this trial relates to.

atherosclerosis coronary artery disorder Inflammation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.